To the best of our knowledge, this is the first study of patients with narcolepsy to examine the effects of the COVID-19 out- break on bedtime and morning wake-up schedules, symptoms, medication, place of work, income, and quality of life during a
3-month-quarantine period. No patient in our sample had a confirmed diagnosis of COVID-19. This can be explained by Brazilian government policy, which sanctions testing only for those with severe symptoms.
Many of the patients with narcolepsy changed their regular workplace, with an increasing number working from home during the pandemic. These changes in workplace environment probably impacted bedtime and wake-time, but no consistent
associations were found between bedtime and wake-time. This finding can be explained by the nature of our convenience sample, as the patients had been followed up regularly in our outpatient clinic for at least 12 months, and some of them have been attending for several years.
Comments